Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Heather M Judge"'
Autor:
Wael Sumaya, William A.E. Parker, Heather M. Judge, Ian R. Hall, Rachel C. Orme, Zulfiquar Adam, James D. Richardson, Alexander M.K. Rothman, Kenneth P. Morgan, Julian P. Gunn, Robert F. Storey
Publikováno v:
Platelets, Vol 32, Iss 4, Pp 555-559 (2021)
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevati
Externí odkaz:
https://doaj.org/article/3333115ba44f4ecd927f58c21aa5c9b6
Autor:
Kok Weng Ow, William A.E. Parker, Mark M. Porter, Jessica Hanson, Heather M. Judge, Norman P. Briffa, Mark R. Thomas, Robert F. Storey
Publikováno v:
Platelets, Vol 31, Iss 7, Pp 945-951 (2020)
Ticagrelor is an antagonist of both platelet adenosine diphosphate (ADP) receptor P2Y12 and equilibrative nucleoside transporter-1. Optimal timing of ticagrelor cessation prior to coronary artery bypass grafting (CABG) remains unclear. We characteriz
Externí odkaz:
https://doaj.org/article/6679e36a3a2e4e2797306c0e383e84d4
Autor:
William A.E. Parker, Rachel C. Orme, Jessica Hanson, Hannah M. Stokes, Claire M. Bridge, Patricia A. Shaw, Wael Sumaya, Kirstie Thorneycroft, Giovanna Petrucci, Benedetta Porro, Heather M. Judge, Ramzi A. Ajjan, Bianca Rocca, Robert F. Storey
Publikováno v:
Platelets, Vol 30, Iss 2, Pp 148-157 (2019)
Higher aspirin doses may be inferior in ticagrelor-treated acute coronary syndrome (ACS) patients and reducing bleeding risk whilst maintaining antithrombotic benefits could improve outcomes. We characterized the pharmacodynamics of a novel dual-anti
Externí odkaz:
https://doaj.org/article/b985dd267bf043f095a2e15eab57596f
Autor:
Aitana Braza-Boïls, Temo Barwari, Clemens Gutmann, Mark R. Thomas, Heather M. Judge, Abhishek Joshi, Raimund Pechlaner, Manu Shankar-Hari, Ramzi A. Ajjan, Ian Sabroe, Robert F. Storey, Manuel Mayr
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8, p 2897 (2020)
There is evidence for the effects of platelet inhibition on innate immune activation. Circulating microRNAs (miRNAs) have been implicated as markers of platelet and leukocyte activation. In the present study, we assessed the effects of P2Y12 inhibito
Externí odkaz:
https://doaj.org/article/5679b627bfee45ee8bdb5994fb5660c7
Autor:
William A.E. Parker, Dominick J. Angiolillo, Fabiana Rollini, Francesco Franchi, Marc P. Bonaca, Deepak L. Bhatt, Ph. Gabriel Steg, Rachel C. Orme, Mark R. Thomas, Heather M. Judge, Marc S. Sabatine, Robert F. Storey
Publikováno v:
Vascular Pharmacology. 149:107145
Autor:
Mark R Thomas, Kok Weng Ow, Heather M Judge, Jessica Hanson, Robert F. Storey, Norman Briffa, Mark M Porter, William A E Parker
Publikováno v:
Platelets. 31:945-951
Ticagrelor is an antagonist of both platelet adenosine diphosphate (ADP) receptor P2Y12 and equilibrative nucleoside transporter-1. Optimal timing of ticagrelor cessation prior to coronary artery bypass grafting (CABG) remains unclear. We characteriz
Autor:
Rachel Orme, Zulfiquar Adam, William A E Parker, Wael Sumaya, Heather M Judge, Ian R Hall, Robert F. Storey, Kenneth P Morgan, Alexander M.K. Rothman, Julian Gunn, James D Richardson
Publikováno v:
Platelets
article-version (VoR) Version of Record
article-version (VoR) Version of Record
A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9020dacd55ef2e25c26cf522a7f4bc2
Autor:
Rachel Orme, Hannah M. Stokes, Robert F. Storey, Benedetta Porro, Claire M. Bridge, Jessica Hanson, William A E Parker, Kirstie Thorneycroft, Ramzi A. Ajjan, Heather M Judge, Giovanna Petrucci, Wael Sumaya, Bianca Rocca, Patricia Shaw
Publikováno v:
Platelets
Higher aspirin doses may be inferior in ticagrelor-treated acute coronary syndrome (ACS) patients and reducing bleeding risk whilst maintaining antithrombotic benefits could improve outcomes. We characterized the pharmacodynamics of a novel dual-anti
Autor:
Nadir Elamin, Thomas Nelson, William Parker, Frances Varian, Georgia Williamson, Hannah McMellon, Jessica Hanson, Janet Middle, Claire Bridge, Heather M. Judge, Norman Briffa, Steven Hunter, Robert F. Storey
Publikováno v:
Journal of the American College of Cardiology. 79:1094
Autor:
Raimund Pechlaner, Clemens Gutmann, Mark R Thomas, Abhishek Joshi, Manuel Mayr, Manu Shankar-Hari, Ian Sabroe, Temo Barwari, Aitana Braza-Boïls, Ramzi A. Ajjan, Robert F. Storey, Heather M Judge
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 8
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
International Journal of Molecular Sciences, Vol 21, Iss 2897, p 2897 (2020)
Volume 21
Issue 8
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
International Journal of Molecular Sciences, Vol 21, Iss 2897, p 2897 (2020)
There is evidence for the effects of platelet inhibition on innate immune activation. Circulating microRNAs (miRNAs) have been implicated as markers of platelet and leukocyte activation. In the present study, we assessed the effects of P2Y12 inhibito